Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma
- 7 November 2014
- journal article
- research article
- Published by Springer Nature in International Journal of Hematology
- Vol. 101 (1) , 46-51
Abstract
Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is a rare extranodal lymphoma with a 5-year survival rate of 80–95 %. There is no standard treatment strategy for pulmonary MALT lymphoma. In the present study, we performed a retrospective evaluation of systemic rituximab monotherapy (375 mg m−2 day−1, 4–8 cycles) as first-line treatment in patients with pulmonary MALT lymphoma. Of the eight patients enrolled, five achieved complete response, one achieved partial response, and two showed stable disease. Median progression-free survival was 66.0 months (range 9.7–87.2 months). Treatment was well tolerated and all patients were alive during the median follow-up period of 64.0 months. Rituximab monotherapy was efficacious in patients with pulmonary MALT lymphoma, demonstrating long-term disease stabilization and symptom reduction. Larger prospective studies are warranted to further assess the efficacy of rituximab monotherapy. In conclusion, rituximab monotherapy may be considered for first-line therapy in patients with pulmonary MALT lymphoma.Keywords
This publication has 40 references indexed in Scilit:
- Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized StudyJournal of Clinical Oncology, 2013
- Clinical characteristics and prognostic factors of pulmonary MALT lymphomaEuropean Respiratory Journal, 2009
- Staging Non-Hodgkin LymphomaCA: A Cancer Journal for Clinicians, 2005
- Primary Pulmonary LymphomaThe Annals of Thoracic Surgery, 2005
- Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare diseaseEuropean Journal of Cancer, 2004
- Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT typeBlood, 2003
- MALT LymphomasHematology-American Society Hematology Education Program, 2001
- Primary non-Hodgkin’s lymphoma of the lungThe Annals of Thoracic Surgery, 2000
- Reactive pulmonary lymphoid disordersHistopathology, 1995
- Primary lymphomas of the lung: morphological, immunohistochemical and clinical featuresHistopathology, 1990